Common SSRI Antidepressants Linked to Higher Fracture Odds

A lot of white pills and a glass of water in the hands of a man, close-up.

A study published in the Injury Prevention Journal suggests that women who were prescribed a common class of antidepressants (Celexa, Paxil, Prozac and Zoloft) to ease menopausal symptoms may face a long-term rise in their risk for bone fracture. Researchers based their findings on more than 137,000 women who were between the ages of 40 and 64 and began SSRI antidepressants between 1998 and 2010.This group was compared to 236,000 women who had only been prescribed indigestion medications and the results concluded that women in the antidepressants SSRI group faced a 76% higher risk for fractures after a single year of SSRI. Via U.S. News. Posted June 26, 2015.

DISCLAIMER: MedShadow provides information and resources related to medications, their effects, and potential side effects. However, it is important to note that we are not a substitute for professional medical advice, diagnosis, or treatment. The content on our site is intended for educational and informational purposes only. Individuals dealing with medical conditions or symptoms should seek guidance from a licensed healthcare professional, such as a physician or pharmacist, who can provide personalized medical advice tailored to their specific circumstances.

While we strive to ensure the accuracy and reliability of the information presented on MedShadow, we cannot guarantee its completeness or suitability for any particular individual's medical needs. Therefore, we strongly encourage users to consult with qualified healthcare professionals regarding any health-related concerns or decisions. By accessing and using MedShadow, you acknowledge and agree that the information provided on the site is not a substitute for professional medical advice and that you should always consult with a qualified healthcare provider for any medical concerns.

Was This Article Helpful?

Show Comments (0)
0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments